Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia)

Molecular Biology Reports

Volumn 40, Issue 11, 2013, Pages 6495-6499

  Salehi, Mohammad Hossein ^a,b   Kamalidehghan, Behnam ^c   Houshmand, Massoud ^b,d   Aryani, Omid ^d   Sadeghizadeh, Majid ^a   Mossalaeie, Mir Majid ^e  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d Special Medical Center Iran   (Iran)

^e Parseh Medical Laboratory   (Iran)

Author keywords

Fibroblast growth factor 21 (FGF 21); Friedreich ataxia (FA); Mitochondrial disorders (MIDs); OXPHOS; Respiratory chain deficiency (RCD)

Indexed keywords

BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR 21;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRIEDREICH ATAXIA; GENETIC ASSOCIATION; HUMAN; IRAN; MALE; PRIMARY MITOCHONDRIAL DISORDER; PROTEIN BLOOD LEVEL; SECONDARY MITOCHONDRIAL DISORDER;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROBLAST GROWTH FACTORS; FRIEDREICH ATAXIA; HUMANS; MALE; MITOCHONDRIAL DISEASES;

EID: 84892715176     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2767-0     Document Type: Article

References (30)

1. Itoh N, Ornitz DM (2004) Evolution of the Fgf and Fgfr gene families. Tren Gen 20(11):563-569
2. Ornitz DM, Itoh N (2001) Fibroblast growth factors. Gen Biol 2(3):3005.3001-3005.3012
3. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Mica-novic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA (2005) FGF-21 as a novel metabolic regulator. J Clin Inv 115(6):1627-1635
4. Tyynismaa H, Raivio T, Hakkarainen A, Ortega-Alonso A, Lundbom N, Kaprio J, Rissanen A, Suomalainen A, Pietiläinen KH (2011) Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins. J Clin Endocrinol Metab 96(2):E351-E355
5. Nishimura T, Nakatake Y, Konishi M, Itoh N (2000) Identification of a novel FGF FGF-21 preferentially expressed in the liver. Biochimica et Biophysica Acta (BBA)-Gen Struct Exp 1492(1):203-206
6. Li H, Bao Y, Xu A, Pan X, Lu J, Wu H, Lu H, Xiang K, Jia W (2009) Serum fibroblast growth factor 21 is associated with adverse lipid profiles and c-glutamyltransferase but not insulin sensitivity in Chinese subjects. J Clin Endocrinol Metab 94(6): 2151-2156
7. Chen W, Li L, Yang G, Li K, Qi X, Zhu W, Tang Y, Liu H, Boden G (2008) Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabet 116(1):65-68
8. Moore DD (2007) Sister act. Science 316(5830):1436-1438
9. Reitman ML (2007) FGF21: a missing link in the biology of fasting. Cell Metab 5(6):405-407
10. Zhang X, Yeung DCY, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RLC, Chow WS, Tso AWK, Lam KSL (2008) Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57(5):1246-1253
11. Wang H, Qiang L, Farmer SR (2008) Identification of a domain within peroxisome proliferator-activated receptor y regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol Cell Biol 28(1):188-200
12. Izumiya Y, Bina HA, Ouchi N, Akasaki Y, Kharitonenkov A, Walsh K (2008) FGF21 is an Akt-regulated myokine. FEBS Lett 582(27):3805-3810
13. Wente W, Efanov AM, Brenner M, Kharitonenkov A, Koster A, Sandusky GE, Sewing S, Treinies I, Zitzer H, Gromada J (2006) Fibroblast growth factor-21 improves pancreatic (J-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55(9):2470-2478
14. Johnson CL, Weston JY, Chadi SA, Fazio EN, Huff MW, Kharitonenkov A, Koester A, Pin CL (2009) Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice. Gastroenterology 137(5):1795-1804
15. Tacer KF, Bookout AL, Ding X, Kurosu H, John GB, Wang L, Goetz R, Mohammadi M, Kuro-o M, Mangelsdorf DJ (2010) Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol 24(10):2050-2064
16. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E (2007) Hepatic fibroblast growth factor 21 is regulated by PPARa and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5(6):426-437
17. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V (2007) Endocrine regulation of the fasting response by PPARa-mediated induction of fibroblast growth factor 21. Cell Metab 5(6):415-425
18. Suomalainen A (2011) Biomarkers for mitochondrial respiratory chain disorders. J Inherit Metab Dis 34(2):277-282
19. Taylor RW, Turnbull DM (2005) Mitochondrial DNA mutations in human disease. Nat Rev Gen 6(5):389-402
20. Skladal D, Halliday J, Thorburn DR (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126(8):1905-1912
21. Chinnery PF (2000) Mitochondrial disorders overview. Gene reviews funded by the NIH developed at the University of Washington, Seattle initial posting
22. Schapira A (2002) Primary and secondary defects of the mitochondrial respiratory chain. J Inherit Metab Dis 25(3):207-214
23. Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, Taylor RW, Chinnery PF, Turnbull DM (2007) Prevalence of mitochondrial DNA disease in adults. Ann Neurol 63(1):35-39
24. DiMauro S, Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348(26):2656-2668
25. Di Donato S (2009) Multisystem manifestations of mitochondrial disorders. J Neurol 256(5):693-710
26. Smeitink JAM (2003) Mitochondrial disorders: clinical presentation and diagnostic dilemmas. J Inherit Metab Dis 26(2): 199-207
27. Shaham O, Slate NG, Goldberger O, Xu Q, Ramanathan A, Souza AL, Clish CB, Sims KB, Mootha VK (2010) A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc Natl Acad Sci 107(4):1571-1575
28. Cuevas-Ramos D, Almeda-Valdes P, Gómez-Pérez FJ, Meza-Arana CE, Cruz-Bautista I, Arellano-Campos O, Navarrete-López M, Aguilar-Salinas CA (2010) Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels. Eur J Endocrinol 163(3):469-477
29. Janssen RJRJ, Nijtmans LG, Heuvel LP, Smeitink JAM (2006) Mitochondrial complex I: structure, function and pathology. J Inherit Metab Dis 29(4):499-515
30. Tyynismaa H, Carroll CJ, Raimundo N, Ahola-Erkkilä S, Wenz T, Ruhanen H, Guse K, Hemminki A, Peltola-Mjøsund KE, Tulkki V (2010) Mitochondrial myopathy induces a starvationlike response. Hum Mol Gen 19(20):3948-3958